TUMORCUBE

Welcome to the Brand page for “TUMORCUBE”, which is offered here for The mark consists of the design of a lined black and white hexagon that also appears to be a cube having depth. in the center of the hexagon design is a pink and white orb having irregular, circular bumps. to the right of the hexagon-and-orb design is the black and pink wording tumorcube, with the letters tumor in black and the letters cube in pink. the unenclosed white space appearing in the drawing, not previously referenced as part of the design or literal elements, is background only and is not claimed as a feature of the mark.;tumor cube;the color(s) pink, black, and white is/are claimed as a feature of the mark.;scientific research and development services, high throughput screening services to support therapeutic and diagnostic drug development; scientific research and development services, the development of assays and cell models for use in high throughput screening for clinical and laboratory use; consulting services for scientific research purposes in the area of high throughput screening and assay design;.

Its status is currently believed to be active. Its class is unavailable. “TUMORCUBE” is believed to be currently owned by “DISCOVERYBIOMED, INC.”

Owner:
DISCOVERYBIOMED, INC.
Owner Details
Description:
The mark consists of the design of a lined black and white hexagon that also appears to be a cube having depth. In the center of the hexagon design is a pink and white orb having irregular, circular bumps. To the right of the hexagon-and-orb design is the black and pink wording TUMORCUBE, with the letters TUMOR in black and the letters CUBE in pink. The unenclosed white space appearing in the drawing, not previously referenced as part of the design or literal elements, is background only and is not claimed as a feature of the mark.;TUMOR CUBE;The color(s) pink, black, and white is/are claimed as a feature of the mark.;Scientific research and development services, high throughput screening services to support therapeutic and diagnostic drug development; scientific research and development services, the development of assays and cell models for use in high throughput screening for clinical and laboratory use; consulting services for scientific research purposes in the area of high throughput screening and assay design;
Categories: